Attached files
file | filename |
---|---|
10-K - FORM 10-K - GENOMIC HEALTH INC | f58029e10vk.htm |
EX-21.1 - EX-21.1 - GENOMIC HEALTH INC | f58029exv21w1.htm |
EX-12.1 - EX-12.1 - GENOMIC HEALTH INC | f58029exv12w1.htm |
EX-31.1 - EX-31.1 - GENOMIC HEALTH INC | f58029exv31w1.htm |
EX-32.1 - EX-32.1 - GENOMIC HEALTH INC | f58029exv32w1.htm |
EX-32.2 - EX-32.2 - GENOMIC HEALTH INC | f58029exv32w2.htm |
EX-31.2 - EX-31.2 - GENOMIC HEALTH INC | f58029exv31w2.htm |
EX-10.14 - EX-10.14 - GENOMIC HEALTH INC | f58029exv10w14.htm |
EX-10.13 - EX-10.13 - GENOMIC HEALTH INC | f58029exv10w13.htm |
EX-10.15 - EX-10.15 - GENOMIC HEALTH INC | f58029exv10w15.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-8 (No.
333-128805) pertaining to the 2005 Stock Incentive Plan and 2001 Stock Incentive Plan of Genomic
Health, Inc., the Registration Statement on Form S-8 (No. 333-163006) pertaining to the 2005 Stock
Incentive Plan of Genomic Health, Inc., and the Registration Statement on Form S-3 (No. 333-167868)
of Genomic Health, Inc. of our reports dated March 11, 2011, with respect to the consolidated
financial statements and schedule of Genomic Health, Inc., and the effectiveness of internal
control over financial reporting of Genomic Health, Inc., included in this Annual Report (Form
10-K) for the year ended December 31, 2010.
/s/ Ernst & Young LLP
Palo Alto, California
March 11, 2011
March 11, 2011